0000895345-24-000245.txt : 20240702
0000895345-24-000245.hdr.sgml : 20240702
20240702205642
ACCESSION NUMBER: 0000895345-24-000245
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis Aaron I.
CENTRAL INDEX KEY: 0001465914
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39485
FILM NUMBER: 241098023
MAIL ADDRESS:
STREET 1: 12860 EL CAMINO REAL, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MVA Investors, LLC
CENTRAL INDEX KEY: 0001468223
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39485
FILM NUMBER: 241098024
BUSINESS ADDRESS:
STREET 1: 12860 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 400-3114
MAIL ADDRESS:
STREET 1: 12860 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tango Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 901
CITY: BOSTON
STATE: MA
ZIP: 02215
BUSINESS PHONE: (857) 320-4900
MAIL ADDRESS:
STREET 1: 201 BROOKLINE AVENUE
STREET 2: SUITE 901
CITY: BOSTON
STATE: MA
ZIP: 02215
FORMER COMPANY:
FORMER CONFORMED NAME: BCTG Acquisition Corp.
DATE OF NAME CHANGE: 20200723
4
1
form4.xml
X0508
4
2024-06-28
0001819133
Tango Therapeutics, Inc.
TNGX
0001468223
MVA Investors, LLC
12860 EL CAMINO REAL
SUITE 300
SAN DIEGO
CA
92130
true
See remarks
0001465914
Davis Aaron I.
12860 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
true
See remarks
false
Common Stock
2024-06-28
4
S
0
29000
8.57
D
314524
D
Common Stock
2024-07-01
4
S
0
110731
8.87
D
203793
D
Common Stock
2024-07-02
4
S
0
95000
8.68
D
108793
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.48 to $8.68, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.75 to $9.00, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.05, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share ("Common Stock"), of Tango Therapeutics, Inc. As to any reporting person that is not a beneficial owner of more than 10% of the outstanding shares of Common Stock, this Form 4 shall not be deemed a concession that such person is subject to Section 16 of the Securities Exchange Act of 1934 with respect to the issuer.
/s/ Aaron I. Davis, Chief Executive Officer, MVA Investors, LLC
2024-07-02
/s/ Aaron I. Davis
2024-07-02